HM-101

N/A

Report date: 2026/03/13 20:02:36
NME

Base Information

Drug NameHM-101
Drug Alias NameCRH receptor1 antagonists (HolsboerMaschmeyer)cortibon program (HMNC Brain Health)CB-2009HM-101
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCorticotropin-releasing factor receptor 1 antagonists
TargetsCorticotropin-releasing factor receptor 1
Therapy Area/IndicationsAnxiety DisordersDepressionSleep Wake Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesHmnc Diagnostics Gmbh
China Registration ClassN/A

Develop Information

Active CompaniesHMNC Holding GmbH
Inactive CompaniesCortibon Pharma GmbHHmnc Diagnostics Gmbh
Active IndicationsAnxiety DisordersDepressionSleep Wake Disorders
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A